Former promoters of pharmaceutical major Ranbaxy Laboratories, Malvinder Mohan Singh and Shivinder Mohan Singh, have been asked to pay damages worth â‚¹2,562 crore by a Singaporean arbitration court. The fine has been imposed on the duo for concealing facts from Japanese pharmaceutical giant Daiichi Sankyo while selling their 34.82% stake in Ranbaxy to the latter for $2.4 billion in 2008.